Neuronetics, Inc. (STIM): Price and Financial Metrics
STIM Price/Volume Stats
| Current price | $3.96 | 52-week high | $5.07 |
| Prev. close | $4.04 | 52-week low | $1.03 |
| Day low | $3.92 | Volume | 23,700 |
| Day high | $4.07 | Avg. volume | 192,604 |
| 50-day MA | $3.87 | Dividend yield | N/A |
| 200-day MA | $2.40 | Market Cap | 118.70M |
STIM Stock Price Chart Interactive Chart >
Neuronetics, Inc. (STIM) Company Bio
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders. It offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment for adult patients with major depressive disorder. The company’s NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed MRI-strength magnetic field, which induces electrical currents designed to stimulate specific areas of the brain associated with mood. Neuronetics, Inc. was founded in 2003 and is based in Malvern, Pennsylvania.
Latest STIM News From Around the Web
Below are the latest news stories about NEURONETICS INC that investors may wish to consider to help them evaluate STIM as an investment opportunity.
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement AccessoryNew accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providersMALVERN, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the U.S. Food and Drug Administration 510(k) clearance of NeuroSite™ Coil Placement Accessory, a state-of-the-art tool that simplifies measu |
NeuroStar TMS Receives Expanded Regulatory Approval in JapanTechnological advances reduce time and increase efficiency for MDD treatmentMALVERN, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has approved multiple proprietary innovations, which significantly advance the patient treatm |
Investors in Neuronetics (NASDAQ:STIM) from five years ago are still down 90%, even after 40% gain this past weekThis month, we saw the Neuronetics, Inc. ( NASDAQ:STIM ) up an impressive 77%. But that doesn't change the fact that... |
Neuronetics to Present at the 35th Annual Piper Sandler Healthcare ConferenceMALVERN, Pa., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the 35th Annual Piper Sandler Healthcare Conference on Wednesday, November 29, 2023. The Company is scheduled to present at 2:00 pm Eastern Time the same day via webcast. A live audio webcas |
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology AdvancementsNew updates designed to advance practice efficiency and patient outcomesMALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced significant updates to the NeuroStar software and TrakStar® Patient Data Management System, a proprietary, HIPAA-compliant, patient management and outcomes reporting |
STIM Price Returns
| 1-mo | 4.49% |
| 3-mo | 23.75% |
| 6-mo | 263.30% |
| 1-year | 91.30% |
| 3-year | -65.57% |
| 5-year | -74.55% |
| YTD | 36.55% |
| 2023 | -57.79% |
| 2022 | 54.04% |
| 2021 | -59.86% |
| 2020 | 147.44% |
| 2019 | -76.80% |
Continue Researching STIM
Here are a few links from around the web to help you further your research on Neuronetics Inc's stock as an investment opportunity:Neuronetics Inc (STIM) Stock Price | Nasdaq
Neuronetics Inc (STIM) Stock Quote, History and News - Yahoo Finance
Neuronetics Inc (STIM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...